FDA
-
-
-
-
-
-
-
Neuronetics Reports First Quarter 2026 Financial and Operating Results
-
-
-
-
-
-
-
Neuronetics Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
-
-
-
-
-
-
-
Neuronetics Announces Selected Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results
-
-
-
-
-
-
-
Neuronetics signs exclusive three-year deal with Elite DNA Behavioral Health
-
-
-
-
-
-
-
Neuronetics Appoints New Chief Financial Officer
-
-
-
-
-
-
-
Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression
-
-
-
-
-
-
-
Neuronetics Announces Launch of Underwritten Public Offering of Common Stock
-
325,297 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

